A Hole in the Roof

American Journal of Medicine

Volumn 121, Issue 11, 2008, Pages 960-962

  Chauhan, Sandeep ^a   Chiu, Yee ^b   Swift, Andrew ^c   Griffiths, Karolina ^d   Moots, Robert J ^b  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b School of Veterinary Science University of Liverpool Leahurst Campus   (United Kingdom)

^c UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FOLIC ACID; GLUCOCORTICOID; METHOTREXATE; METHYLPREDNISOLONE;

ADULT; ARTICLE; BIOPSY; CASE REPORT; HUMAN; HYPEREKPLEXIA; MALE; NOSE MALFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 54349084009     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.07.014     Document Type: Note

References (19)

1. Klinger H. Borderline variants of periarteritis nodosa. Frankf Z Pathol 42 (1931) 455-480
2. Wegener F. About generalised septic vascular diseases. Verh Deut Pathol Ges 29 (1936) 202-210
3. Wegener F. About a peculiar rhinogenic granulomatosis with marked involvement of the arterial system and kidneys. Beitr Pathol Anat 102 (1939) 30-68
4. Stone JH for the Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 48 (2003) 2299-2309
5. Mohammad A.J., Jacobsson L.T., Mahr A.D., et al. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome withi a defined population in southern Sweden. Rheumatology (Oxford) 46 (2007) 1329-1337
6. Reinhold-Keller E., Herlyn K., Wagner-Bastmeyer R., and Gross W.L. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53 (2005) 93-99
7. Cotch M.F., Hoffman G.S., Yerg D.E., et al. epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 39 (1996) 87-92
8. Hoffman G.S., Kerr G.S., Leavitt R.Y., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116 (1992) 488-498
9. Reinhold-Keller E., Beuge N., Latza U., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43 (2000) 1021-1032
10. Simsek S., de Vries X.H., Jol J.A., et al. Sino-nasal bony and cartilaginous destruction associated with cocaine abuse, S. aureus, and antineutrophil cytoplasmic antibodies. Neth J Med 64 (2006) 248-251
11. Savige J., Davies D., Falk R.J., et al. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 57 (2000) 846-862
12. Bosch X., Guilabert A., and Font J. Antineutrophil cytoplasmic antibodies. Lancet 368 (2006) 404-418
13. Yazici Y. Vasculitis update, 2007. Bull NYU Hosp Jt Dis. 65 (2007) 212-214
14. Devaney K.O., Travis W.D., Hoffman G., et al. Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 14 (1990) 555-564
15. Blanksma C.J., and Brand H.S. Cocaine abuse: orofacial manifestations and implications for dental treatment. Int Dent J 55 (2005) 365-369
16. Barrak H.A. Hard palate perforation due to mucormycosis: report of 4 cases. J Laryngol Otol 121 (2007) 1099-1102
17. Vargas-Aguayo A.M., and López-Pérez V.M. Centrofacial lymphoma, cause of middle line granuloma syndrome. Report of a case. Gac Med Mex 134 (1998) 743-746
18. Lavalle C., Gudiño J., Reinoso S.R., et al. Behçet's syndrome and palate perforation. Arthritis Rheum 22 (1979) 308
19. Lamprecht P., Till A., Steinmann J., et al. Current state of biologicals in the management of systemic vasculitis. Ann N Y Acad Sci 1110 (2007) 261-270